Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin
- PMID: 38569737
- PMCID: PMC10989128
- DOI: 10.1136/bcr-2023-259485
Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin
Abstract
This case report describes a rare manifestation of acute compartment syndrome (ACS) involving all four extremities, precipitated by angio-oedema in a middle-aged woman who consumed an overdose of multiple medications: nifedipine, azelnidipine, amlodipine besylate, olmesartan medoxomil, telmisartan, esaxerenone and vildagliptin. She presented with haemodynamic instability, necessitating intubation. Despite stabilising haemodynamic parameters within 24 hours, she manifested escalating extremity oedema. At 52 hours after ingestion, mottled skin was observed, along with necrotic alterations in the swollen hands and compartment pressures exceeding 30 mm Hg in all extremities. ACS was diagnosed, leading to fasciotomies. The aetiology is postulated to be drug-induced angio-oedema, possibly intensified by the concurrent overdose of olmesartan medoxomil, telmisartan and vildagliptin, each of which has a risk of angio-oedema even at standard dosages. This scenario is a very rare case caused by drug-induced angio-oedema, which underscores the importance of vigilant monitoring to detect ACS in patients with progressing limb oedema.
Keywords: Adult intensive care; Drug interactions; Drugs misuse (including addiction); Orthopaedic and trauma surgery.
© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.Am J Cardiovasc Drugs. 2007;7(5):361-72. doi: 10.2165/00129784-200707050-00006. Am J Cardiovasc Drugs. 2007. PMID: 17953475 Clinical Trial.
-
Olmesartan medoxomil/amlodipine.Drugs. 2009;69(6):717-29. doi: 10.2165/00003495-200969060-00005. Drugs. 2009. PMID: 19405551 Review.
-
Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.Blood Press Monit. 2006 Jun;11(3):135-41. doi: 10.1097/01.mbp.0000209087.40117.b3. Blood Press Monit. 2006. PMID: 16702822 Clinical Trial.
-
Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.Clin Drug Investig. 2009;29(1):11-25. doi: 10.2165/0044011-200929010-00002. Clin Drug Investig. 2009. PMID: 19067471 Clinical Trial.
-
Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.Drugs. 2011 Jan 22;71(2):209-20. doi: 10.2165/11206770-000000000-00000. Drugs. 2011. PMID: 21275446 Review.
References
-
- Caballero T, Baeza ML, Cabañas R, et al. . Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. part II. treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 2011;21:422–41; . - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical